Product Overview: Somatropin is a peptide hormone secreted by the anterior lobe of the pituitary gland. It promotes the growth of bones, internal organs, and the entire body, stimulates protein synthesis, and influences lipid and mineral metabolism. This product is obtained through secretory expression in Escherichia coli engineered for high-level expression of the hGH gene, followed by fermentation and purification, comprises 191 amino acid residues, and its spatial conformation, amino acid sequence, and physiological and pharmacological actions are identical to those of natural human growth hormone.   Indications: Growth retardation in children due to endogenous growth hormone deficiency Short stature in children with Noonan syndrome Short stature or growth retardation in children with SHOX gene deficiency Growth retardation in children with Prader-Willi syndrome (PWS) Idiopathic short stature (ISS) Treatment of severe burns Short stature in children with achondroplasia Short bowel syndrome in adults receiving nutritional support Growth retardation in girls with gonadal dysgenesis (Turner syndrome) Short stature in children born small for gestational age (SGA) who have not achieved catch-up growth by age 2 Growth retardation in prepubertal children with chronic kidney disease (CKD) Growth hormone deficiency caused by confirmed hypothalamic-pituitary disease, or marked growth hormone deficiency confirmed by two different growth hormone stimulation tests

For the improvement of neurological deficits in patients with acute ischemic stroke.

Lidocaine and Prilocaine Cream, as a compound amide-type local anesthetic, provides dermal anesthesia by releasing lidocaine and prilocaine from the cream matrix into the epidermis and dermis, as well as to nearby pain receptors and nerve endings. Both agents stabilize the neuronal membrane by inhibiting the ion transport required for the generation and transmission of impulses, thereby achieving local anesthesia.   This product is indicated for local anesthesia of the skin in the following situations: Needle puncture, e.g., insertion of catheters or blood sampling. Superficial surgical procedures, e.g., prior to superficial surgical procedures or infiltration anesthesia on genital mucosa; cleaning/debridement of leg ulcers.

For progesterone supplementation during assisted reproductive technology (ART) in women who cannot use or cannot tolerate vaginal formulations.

This product is indicated for chronic weight management in adult patients, as an adjunct to a reduced-calorie diet and increased physical activity, in patients with an initial body mass index (BMI) of: ≥ 30 kg/m² (obese); ≥ 27 kg/m² to < 30 kg/m² (overweight) with at least one weight-related comorbidity, such as hyperglycemia, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease.